Compare Inocycle Technology Group Tbk. (INOV) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inocycle Technology Group Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Inocycle Technology Group Tbk. trades at Rp138 (market cap 253.15B, 4.59M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Inocycle Technology Group Tbk. is far larger — about 2.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| INOV | SCPI | |
|---|---|---|
Market Cap | 253.15B | 104.4B |
Volume | 4.59M | — |
Lot | 45.92K | — |
Turnover | 648.5M | — |
Average Price | 141.24 | — |
Value | 648.5M | — |
Indicative Equilibrium Price | 138 | — |
Indicative Equilibrium Volume | 91 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inocycle Technology Group Tbk.
PT Inocycle Technology Group Tbk (The Company) formerly known PT Hilon Felt (the “Company”) was established based on Deed of Establishment No. 35 dated 17 July 2001 which was made in the presence of Fransiscus Xaverius Budi Santoso Isbandi, S.H., a notary in Jakarta.
Read more on INOV →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
